The Rise of Stem Cell Culture Technologies: Market Implications 2023 to 2033


 The Cell Culture Market is now a vital resource for scientists and researchers working in the field of biotechnology. In order to research cells' behaviour and create diverse applications, it entails keeping and growing cells outside of their natural habitat. The demand for biopharmaceuticals, increased research activity, and technological improvements have all contributed to the tremendous rise that has been seen in the cell culture market in recent years.

The use of cell culture has increased in a variety of fields, such as medicines, biotechnology, regenerative medicine, and academic study. In order to examine the effectiveness and toxicity of novel chemicals, cell culture techniques are vital in the discovery and development of new drugs. Additionally, the manufacture of biopharmaceuticals using cell cultures has become quite popular, which has increased demand for cell culture-related goods and services.

Accelerate Your Success: Unlock the Secrets of the Cell Culture Market  - Download the Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14318

The size of the global cell culture market was evaluated at US$ 25.4 billion in 2022 and will be worth US$ 29.0 billion in 2023. Additionally, due to rising demand for biopharmaceuticals like vaccines and stem cells as well as increased R&D efforts, the global cell culture market is anticipated to grow at an astounding CAGR of 11.8% between 2023 and 2033, surpassing a valuation of roughly US$ 88.6 billion by that year. The worldwide cell culture market has seen rapid expansion, and this pattern is anticipated to remain for the foreseeable future. This expansion is being fueled by factors including rising R&D expenditures, rising biologics demand, and rise in chronic diseases. Additionally, the introduction of sophisticated bioreactor systems and automated cell culture methods is anticipated to further support market expansion.

Cell Culture Application in Pharma & Health is Key to Market Growth

At the moment, innovations are fueling market expansion. The need for sophisticated versions of cell culture products is growing as a result of significant investments made by various end-user groups in this area. Similar to how biosimilars have a favourable impact on market prospects, there is a rising need for innovative therapies.

All of these elements have worked together to carve out a specific application for cell culture in the pharmaceutical and healthcare industries. This is mostly brought on by the steady increase in cardiovascular, renal, and cancer disorders. Cell culture can open up lucrative opportunities for the pharmaceutical and healthcare industries to flourish as consumer demand for cutting-edge treatment solutions rises.

Key Takeaways from the Report:

  • Between 2017 and 2022, the market recorded a CAGR of 13.5%, attaining a valuation of US$ 25.4 billion by 2022.
  • During the forecast period, the United States market is projected to expand at a CAGR of 11.6% and reach a valuation of US$ 31.4 billion by 2033.
  • Between 2023 and 2033, the United Kingdom market is expected to record a CAGR of 10.9%, to attain a valuation of US$ 3.7 billion by 2033.
  • The consumables segment is projected to register a CAGR of 11.4% during the forecast period.
  • The biopharmaceutical production segment is anticipated to witness a CAGR of 11.1% during the forecast period.

Key Market Developments:

  • In January 2022, Cytiva (Danaher Corporation) announced its collaboration with Nucleus Biologics. This can be an important step towards developing custom culture media for cell as well as gene therapies.
  • In February 2022, KromaTiD enhanced its services by venturing into cell and blood culture isolation, and processing, coupled with quality control service.

Key Players:

  • Danaher Corporation
  • Thermo Fisher Scientific
  • Becton
  • Dickinson and Company
  • Corning Incorporated
  • Merck KgaA
  • PromoCell GmbH
  • Sartorius AG

Key Segments

By Product:

  • Consumables
    • Sera
    • Media
    • Reagents
    • Vessels
    • Accessories
  • Equipment
    • Supporting Equipment
    • Bioreactors
    • Storage Equipment

By Application:

  • Biopharmaceutical Production
    • Monoclonal antibodies
    • Vaccines production
    • Other therapeutic proteins
  • Diagnostics
    • Drug Screening & Development
      • Tissue Engineering & Regenerative Medicine
    • Cell and gene therapy
  • Others

By End User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa (MEA)

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more